Purpose | This immunoassay kit allows for the specific measurement of human Placenta Growth Factor ,PlGF concentrations in cell culture supernates, urine, serum, and plasma. |
Sample Type | Cell Culture Supernatant, Urine, Serum, Plasma |
Analytical Method | Quantitative |
Detection Method | Colorimetric |
Specificity | This assay recognizes recombinant and natural human PlGF. |
Cross-Reactivity (Details) | No significant cross-reactivity or interference was observed. |
Characteristics | Homo sapiens,Human,Placenta growth factor,PlGF,PGF,PGFL,PLGF |
Components |
Reagent (Quantity):
|
Material not included | Microplate reader. Pipettes and pipette tips. EP tube Deionized or distilled water. |
Alternative Name | PGF (PGF ELISA Kit Abstract) |
Background | Based on sequence and structural similarities, Placenta Growth Factor (PlGF) is a member of the Vascular Endothelial Growth Factor (VEGF) family that also includes VEGF/VEGF-A, VEGF-B, VEGF-C, VEGF-D, and VEGF-E (viral). PlGF is also related, albeit more distantly, to the PDGF family of growth factors. The VEGF family is widely known for its roles in the development and/or growth of the vascular or lymphatic endothelia. The PlGF sequence predicts a 149 amino acid (aa) mature protein with a 21 aa signal sequence and a centrally located PDGF-like domain with 8 conserved cysteine residues that form a cysteine knot structure. PlGF shares approximately 42% aa sequence identity with VEGF, and the two share significant structural similarity. Although PlGF does not share the pro-angiogenic receptor VEGF R2 with VEGF, both bind VEGF R1 (soluble and transmembrane forms), Neuropilin-1, and Neuropilin-2. VEGF and PlGF appear to have different effects on VEGF R1 activity and, subsequently, affect the expression of different downstream genes. PlGF exists in at least 4 alternatively spliced forms: PlGF-1, PlGF-2, PlGF-3, and PlGF-4. Notable differences between these forms include the insertion of a heparin-binding domain in PlGF-2 and PlGF-4 that might result in increased association with the cell membrane or altered affinities for PlGF receptors. In mice, only the PlGF-2 ortholog has been described and shares 65% aa identity with its human counterpart (18). As the name reflects, PlGF was first identified in human placenta, and indeed, is expressed prominently in placenta under normal conditions. Other tissues and cell types expressing PlGF include microvascular and human umbilical vein endothelia, bone marrow, uterine natural killer cells, and keratinocytes. It is also upregulated under certain pathological conditions including wound healing and tumor formation. |
Pathways | VEGFR1 Specific Signals |
Sample Volume | 100 μL |
Plate | Pre-coated |
Protocol | This assay employs the quantitative sandwich enzyme immunoassay technique. A monoclonal antibody specific for PlGF has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and any PlGF present is bound by the immobilized antibody. An enzyme-linked polyclonal antibody specific for PlGF is added to the wells. Following a wash to remove any unbound antibody-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of PlGF bound in the initial step. The color development is 2 stopped and the intensity of the color is measured. |
Reagent Preparation |
Bring all reagents to room temperature before use. Wash Buffer - If crystals have formed in the concentrate, warm to room temperature and mix gently until the crystals have completely dissolved. Dilute 30 mL of Wash Buffer Concentrate into deionized or distilled water to prepare 750 mL of Wash Buffer. Standard - Reconstitute the Standard with 1.0 mL of Sample Diluent. This reconstitution produces a stock solution. Allow the standard to sit for a minimum of 15 minutes with gentle agitation prior to making serial dilutions (Making serial dilution in the wells directly is not permitted). The undiluted standard serves as the high standard. The Sample Diluent serves as the zero standard (0 ng/ml). |
Sample Collection | Cell culture supernates - Remove particulates by centrifugation and assay immediately or aliquot and store samples at ≤ -20 °C. Avoid repeated freeze-thaw cycles. Serum - Use a serum separator tube (SST) and allow samples to clot for 30 minutes before centrifugation for 15 minutes at approximately 1000 x g. Remove serum and assay immediately or aliquot and store samples at -20 °C. Plasma - Collect plasma using EDTA or heparin as an anticoagulant. Centrifuge samples for 15 minutes at 1000 x g at 2 - 8 °C within 30 minutes of collection. Store samples at ≤ -20 °C. Avoid repeated freeze-thaw cycles. Urine - Aseptically collect the first urine of the day (mid-stream), voided directly into a sterile container. Centrifuge to remove particulate matter, assay immediately or aliquot and store at ≤ -20 °C. Avoid repeated freeze-thaw cycles. |
Assay Procedure |
Allow all reagents to reach room temperature (Please do not dissolve the reagents at 37 °C directly.). All the reagents should be mixed thoroughly by gently swirling before pipetting. Avoid foaming. Keep appropriate numbers of strips for 1 experiment and remove extra strips from microtiter plate. Removed strips should be resealed and stored at 4 °C until the kits expiry date. Prepare all reagents, working standards and samples as directed in the previous sections. Please predict the concentration before assaying. If values for these are not within the range of the standard curve, users must determine the optimal sample dilutions for their particular experiments. |
Calculation of Results |
Average the duplicate readings for each standard, control, and sample and subtract the average zero standard optical density. Create a standard curve by reducing the data using computer software capable of generating a four parameter logistic (4-PL) curve-fit. As an alternative, construct a standard curve by plotting the mean absorbance for each standard on the x-axis against the concentration on the y-axis and draw a best fit curve through the points on the graph. The data may be linearized by plotting the log of the SAA concentrations versus the log of the O.D. and the best fit line can be determined by regression analysis. It is recommended to use some related software to do this calculation, such as curve expert 13.0. This procedure will produce an adequate but less precise fit of the data. If samples have been diluted, the concentration read from the standard curve must be multiplied by the dilution factor. |
Restrictions | For Research Use only |
Handling Advice |
1. The kit should not be used beyond the expiration date on the kit label. 2. Do not mix or substitute reagents with those from other lots or sources. 3. If samples generate values higher than the highest standard, further dilute the samples with the Assay Diluent and repeat the assay. Any variation in standard diluent, operator, pipetting technique, washing technique,incubation time or temperature, and kit age can cause variation in binding. 4. This assay is designed to eliminate interference by soluble receptors, ligands, binding proteins, and other factors present in biological samples. Until all factors have been tested in the Immunoassay, the possibility of interference cannot be excluded. |
Storage | 4 °C/-20 °C |
Storage Comment | The Assay Plate, Standard, Detection Reagent A and Detection Reagent B should be stored at -20°C upon being received. After receiving the kit , Substrate should be always stored at 4°C. |
Supplier Images |
|
Product cited in: |
Li, Liu, Bin, Wang, Chen, Xiu, Pei, Lai, Chen, Fan, Xie, Tao, Wu: "Mutant hypoxia inducible factor-1? improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle." in: Microvascular research, Vol. 81, Issue 1, pp. 26-33, 2011 (PubMed).
|